Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid‐Lowering Medication: A Cohort Study

Background Lifestyle modification is a key component of cardiovascular disease prevention before and concurrently with pharmacologic interventions. We evaluated whether lifestyle factors change in relation to the initiation of antihypertensive or lipid‐lowering medication (statins). Methods and Resu...

Full description

Bibliographic Details
Main Authors: Maarit J. Korhonen, Jaana Pentti, Juha Hartikainen, Jenni Ilomäki, Soko Setoguchi, Danny Liew, Mika Kivimäki, Jussi Vahtera
Format: Article
Language:English
Published: Wiley 2020-02-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.014168
_version_ 1797884448735232000
author Maarit J. Korhonen
Jaana Pentti
Juha Hartikainen
Jenni Ilomäki
Soko Setoguchi
Danny Liew
Mika Kivimäki
Jussi Vahtera
author_facet Maarit J. Korhonen
Jaana Pentti
Juha Hartikainen
Jenni Ilomäki
Soko Setoguchi
Danny Liew
Mika Kivimäki
Jussi Vahtera
author_sort Maarit J. Korhonen
collection DOAJ
description Background Lifestyle modification is a key component of cardiovascular disease prevention before and concurrently with pharmacologic interventions. We evaluated whether lifestyle factors change in relation to the initiation of antihypertensive or lipid‐lowering medication (statins). Methods and Results The study population comprised 41 225 participants of the FPS (Finnish Public Sector) study aged ≥40 years who were free of cardiovascular disease at baseline and responded to ≥2 consecutive surveys administered in 4‐year intervals in 2000–2013. Medication use was ascertained through pharmacy‐claims data. Using a series of pre–post data sets, we compared changes in body mass index, physical activity, alcohol consumption, and smoking between 8837 initiators and 46 021 noninitiators of antihypertensive medications or statins. In participants who initiated medication use, body mass index increased more (difference in change 0.19; 95% CI, 0.16–0.22) and physical activity declined (−0.09 metabolic equivalent of task hour/day; 95% CI, −0.16 to −0.02) compared with noninitiators. The likelihood of becoming obese (odds ratio: 1.82; 95% CI, 1.63–2.03) and physically inactive (odds ratio: 1.08; 95% CI, 1.01–1.17) was higher in initiators. However, medication initiation was associated with greater decline in average alcohol consumption (−1.85 g/week; 95% CI, −3.67 to −0.14) and higher odds of quitting smoking (odds ratio for current smoking in the second survey: 0.74; 95% CI, 0.64–0.85). Conclusions These findings suggest that initiation of antihypertensive and statin medication is associated with lifestyle changes, some favorable and others unfavorable. Weight management and physical activity should be encouraged in individuals prescribed these medications.
first_indexed 2024-04-10T04:06:26Z
format Article
id doaj.art-fb894147cadc4d329853c3db3e9362da
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-04-10T04:06:26Z
publishDate 2020-02-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-fb894147cadc4d329853c3db3e9362da2023-03-13T05:25:33ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802020-02-019410.1161/JAHA.119.014168Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid‐Lowering Medication: A Cohort StudyMaarit J. Korhonen0Jaana Pentti1Juha Hartikainen2Jenni Ilomäki3Soko Setoguchi4Danny Liew5Mika Kivimäki6Jussi Vahtera7Department of Public Health University of Turku FinlandFinnish Institute of Occupational Health Helsinki FinlandHeart Center Kuopio University Hospital Kuopio FinlandCentre for Medicine Use and Safety Faculty of Pharmacy and Pharmaceutical Sciences Monash University Melbourne Victoria AustraliaRutgers School of Public Health and Rutgers Robert Wood Johnson Medical School New Brunswick NJSchool of Public Health and Preventive Medicine Monash University Melbourne Victoria AustraliaFinnish Institute of Occupational Health Helsinki FinlandDepartment of Public Health University of Turku FinlandBackground Lifestyle modification is a key component of cardiovascular disease prevention before and concurrently with pharmacologic interventions. We evaluated whether lifestyle factors change in relation to the initiation of antihypertensive or lipid‐lowering medication (statins). Methods and Results The study population comprised 41 225 participants of the FPS (Finnish Public Sector) study aged ≥40 years who were free of cardiovascular disease at baseline and responded to ≥2 consecutive surveys administered in 4‐year intervals in 2000–2013. Medication use was ascertained through pharmacy‐claims data. Using a series of pre–post data sets, we compared changes in body mass index, physical activity, alcohol consumption, and smoking between 8837 initiators and 46 021 noninitiators of antihypertensive medications or statins. In participants who initiated medication use, body mass index increased more (difference in change 0.19; 95% CI, 0.16–0.22) and physical activity declined (−0.09 metabolic equivalent of task hour/day; 95% CI, −0.16 to −0.02) compared with noninitiators. The likelihood of becoming obese (odds ratio: 1.82; 95% CI, 1.63–2.03) and physically inactive (odds ratio: 1.08; 95% CI, 1.01–1.17) was higher in initiators. However, medication initiation was associated with greater decline in average alcohol consumption (−1.85 g/week; 95% CI, −3.67 to −0.14) and higher odds of quitting smoking (odds ratio for current smoking in the second survey: 0.74; 95% CI, 0.64–0.85). Conclusions These findings suggest that initiation of antihypertensive and statin medication is associated with lifestyle changes, some favorable and others unfavorable. Weight management and physical activity should be encouraged in individuals prescribed these medications.https://www.ahajournals.org/doi/10.1161/JAHA.119.014168antihypertensive agentslifestylelongitudinalprimary preventionstatins
spellingShingle Maarit J. Korhonen
Jaana Pentti
Juha Hartikainen
Jenni Ilomäki
Soko Setoguchi
Danny Liew
Mika Kivimäki
Jussi Vahtera
Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid‐Lowering Medication: A Cohort Study
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
antihypertensive agents
lifestyle
longitudinal
primary prevention
statins
title Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid‐Lowering Medication: A Cohort Study
title_full Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid‐Lowering Medication: A Cohort Study
title_fullStr Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid‐Lowering Medication: A Cohort Study
title_full_unstemmed Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid‐Lowering Medication: A Cohort Study
title_short Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid‐Lowering Medication: A Cohort Study
title_sort lifestyle changes in relation to initiation of antihypertensive and lipid lowering medication a cohort study
topic antihypertensive agents
lifestyle
longitudinal
primary prevention
statins
url https://www.ahajournals.org/doi/10.1161/JAHA.119.014168
work_keys_str_mv AT maaritjkorhonen lifestylechangesinrelationtoinitiationofantihypertensiveandlipidloweringmedicationacohortstudy
AT jaanapentti lifestylechangesinrelationtoinitiationofantihypertensiveandlipidloweringmedicationacohortstudy
AT juhahartikainen lifestylechangesinrelationtoinitiationofantihypertensiveandlipidloweringmedicationacohortstudy
AT jenniilomaki lifestylechangesinrelationtoinitiationofantihypertensiveandlipidloweringmedicationacohortstudy
AT sokosetoguchi lifestylechangesinrelationtoinitiationofantihypertensiveandlipidloweringmedicationacohortstudy
AT dannyliew lifestylechangesinrelationtoinitiationofantihypertensiveandlipidloweringmedicationacohortstudy
AT mikakivimaki lifestylechangesinrelationtoinitiationofantihypertensiveandlipidloweringmedicationacohortstudy
AT jussivahtera lifestylechangesinrelationtoinitiationofantihypertensiveandlipidloweringmedicationacohortstudy